Search for:

In brief

In the context of their surveillance activity against pharmaceutical cybercrimes, the Italian Anti-Adulteration Units (NAS) ordered the shutdown of four websites that unlawfully performed the online sale of drugs and vaccines with alleged therapeutic properties for the treatment of COVID-19.


For the same reasons, in 2020, the NAS had already blocked 237 websites, 217 of which sold products related to the pandemic emergency. In addition to several prescription-only medicinal products whose sale was restricted to pharmacies, the NAS also identified and blocked the sale of unlicensed drugs, medicines containing active ingredients subject to particular restrictions on use or specific indications in relation to the SAR-CoV-2 infection and alleged vaccines against COVID-19.

Author

Roberto Cursano has been a lawyer in Baker McKenzie since September 2007. He focuses on healthcare law and compliance, and assists in tender procedures, the negotiation of public contracts and litigation before administrative courts. Mr. Cursano is a former administrative officer in the Italian Ministry of Health and helps clients work closely with the Italian Public Administration. He is admitted to the bar before the Italian Supreme Court and the Council of State. As well as training and tutoring in the master’s degree program on clinical trials of pharmaceutical products at the University of Rome Sapienza, Mr. Cursano regularly publishes articles and scientific contributions. He also frequently hosts and participates in seminars and presentations on pharmaceutical and administrative law matters.

Author

Riccardo Ovidi is an Associate in Baker McKenzie Rome office.